MRP3 expression is associated to a low survival rate [30], however, many studies show that inhibition of MRP1 activity is sufficient to chemosensitize GBM cells to antitumoural agents that are substrates of this transporter, such as vincristine and etoposide [5, 8, 20]. Here, ABCC3 is linked to glioblastoma.